Importance of minimal residual disease testing during the second year of therapy for children with acute lymphoblastic leukemia

G Marshall, M Haber, E Kwan, L Zhu, D Ferrara, X Chengyuan, Michael Brisco, Pamela Sykes, Alexander Morley, Webster, L Dalla Pozza, K Waters, M Norris

    Research output: Contribution to journalArticle

    45 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)704-709
    Number of pages6
    JournalJournal of Clinical Oncology
    Volume21
    Issue number4
    Publication statusPublished - 2003

    Cite this